We are live on ! Find out more
LSTA icon

Lisata Therapeutics
LSTA

32 hedge funds and large institutions have $3.37M invested in Lisata Therapeutics in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

600% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 1

38% more capital invested

Capital invested by funds: $2.44M → $3.37M (+$933K)

33% more funds holding

Funds holding: 24 → 32 (+8)

0.07% more ownership

Funds ownership: 0.59% → 0.66% (+0.07%)

70% less call options, than puts

Call options by funds: $170K | Put options by funds: $558K

Holders
32
Holders Change
+8
Holders Change %
+33.33%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
1
Closed
1
Calls
$170K
Puts
$558K
Net Calls
-$388K
Net Calls Change
-$630K

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$202K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$180K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$151K
4
Renaissance Technologies
Renaissance Technologies
New York
+$144K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$134K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$19K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$7.02K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$1.67M +$144K +4,551 +8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$586K +$151K +4,774 +28%
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$282K +$180K +5,677 +119%
SM
4
Sabby Management
Florida
$173K +$202K +6,400 New
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$114K +$134K +4,225 New
Citadel Advisors
6
Citadel Advisors
Florida
$102K +$119K +3,771 New
CIBC Private Wealth Group
7
CIBC Private Wealth Group
Georgia
$100K +$117K +3,702 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$83K – – –
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$59K -$7.02K -222 -9%
BlackRock
10
BlackRock
New York
$54K – – –
STA
11
Summit Trail Advisors
New York
$27K – – –
TRCT
12
Tower Research Capital (TRC)
New York
$24K +$10.7K +339 +62%
Morgan Stanley
13
Morgan Stanley
New York
$20K +$15K +474 +192%
Creative Planning
14
Creative Planning
Kansas
$18K – – –
WB
15
WesBanco Bank
West Virginia
$18K – – –
Osaic Holdings
16
Osaic Holdings
Arizona
$16K – – –
Simplex Trading
17
Simplex Trading
Illinois
$15K +$18K +568 New
Group One Trading
18
Group One Trading
Illinois
$4K +$5.03K +159 New
Bank of America
19
Bank of America
North Carolina
$2K +$791 +25 +76%
Northwestern Mutual Wealth Management
20
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$1K – – –
TWA
22
TCI Wealth Advisors
Arizona
$1K +$632 +20 New
Millennium Management
23
Millennium Management
New York
$44 +$52K +1,644 New
KFS
24
Kelly Financial Services
Massachusetts
$18 – – –
RE
25
RBC Europe
United Kingdom
$18 – – –
1
2

LSTA Hedge Fund Activity: Q3 2020 in Review

32 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q3 2020, worth a combined $3.37M — up 38% from $2.44M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new LSTA positions and 1 closed out — a net gain of 8 holders — while 7 added to existing stakes and 1 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $202K. The largest seller was Jane Street, exiting entirely with an estimated $19K sold.

  • 32 institutional investors held Lisata Therapeutics (LSTA) as of Q3 2020, up from 24 in Q2 2020.
  • Funds reported $3.37M of Lisata Therapeutics stock for Q3 2020, up 38% quarter-over-quarter.
  • 9 funds opened new Lisata Therapeutics positions in Q3 2020 and 1 closed out, a net change of +8 holders.
  • The largest Lisata Therapeutics buyer in Q3 2020 was Sabby Management, an estimated $202K added.
  • The largest Lisata Therapeutics seller in Q3 2020 was Jane Street, an estimated $19K sold.

Based on aggregated 13F filings for Q3 2020.